Medhealth Review

Patient Engagement in Managing Chronic Metabolic Diseases: A Technological Perspective

The healthcare landscape is undergoing a significant transformation, with patient engagement emerging as a pivotal element in the management of chronic metabolic diseases such as diabetes, hypertension, and Non-Alcoholic Fatty Liver Disease (NAFLD). The advent of medical technology is reshaping the dynamics of patient care, enhancing interactions between patients and healthcare providers. This article aims to explore the synergy between patient engagement and technological advancements, highlighting their crucial impact on the management of chronic diseases.

Technological Innovations Transforming Patient Care

Medical devices and digital health tools have revolutionized the realm of patient care. Wearable technologies for continuous monitoring of vital parameters, like blood glucose and blood pressure, and applications for tracking liver health, exemplify this transformation. These tools provide real-time data, enabling patients to make informed health decisions. The immediacy of this data fosters a more dynamic and collaborative approach between patients and healthcare providers, enhancing disease management.

Clinical Trials: The Backbone of Medical Device Development

The development and refinement of medical technologies are contingent upon rigorous clinical trial management. These trials are essential for assessing the efficacy, safety, usability, and patient adherence to medical devices, ensuring their applicability and reliability in real-world settings. Contract Research Organizations (CROs) play a crucial role in this process, offering specialized expertise in navigating the complexities associated with device trials.

The Integral Role of CROs in Bridging Research and Application

CROs are instrumental in the translation of medical research into practical applications. They offer comprehensive solutions encompassing regulatory compliance, patient recruitment, and trial management. This involvement is pivotal in transforming innovative research into practical, market-ready health technologies that significantly enhance patient engagement and disease management.

Empowering Patients through Digital Health Tools

The heart of this technological revolution is patient empowerment. Access to personalized health data and tools has redefined the role of patients from passive recipients to active participants in their health management. This empowerment leads to enhanced adherence to treatment plans, lifestyle changes, and ultimately, improved health outcomes. The psychological benefits of empowerment, where patients feel in control of their health, significantly contribute to their overall well-being.

Digital Twin (DT) Technology: A Game-Changer in Chronic Disease Management

The Digital Twin (DT) model is a prime example of advanced technology enhancing patient engagement in chronic disease management. A study presented at EASD 2023 highlighted the effectiveness of DT in improving glycemic control and body weight in patients with Type 2 Diabetes Mellitus (T2DM), based on the frequency of app usage. The DT platform, leveraging Artificial Intelligence (AI) and the Internet of Things (IoT), integrates multi-dimensional data to deliver precise nutrition and health recommendations through a mobile app and personalized coaching​​. The predictive capabilities of DT in guiding patients towards the remission of chronic metabolic conditions underscore the potential of technology in proactive health management. A study by Shamanna et al. (2020) demonstrated the efficacy of DT in reducing HbA1c in patients with Type 2 Diabetes Mellitus (T2DM) using precision nutrition, underscoring the potential of technology in proactive health management. The predictive capabilities of DT in guiding patients towards remission of chronic metabolic conditions highlight the potential of technology in proactive health management.

The Future of Healthcare: Technology-Driven Patient Engagement

Looking ahead, the role of technology in patient engagement is set to become increasingly prominent. The continuous evolution of medical devices and digital health platforms is expected to bring about more personalized, efficient, and effective management of chronic diseases. This shift towards technology-driven patient care necessitates a collaborative effort among healthcare professionals, technology developers, and patients to maximize the benefits of these innovations.

Challenges and Opportunities

While the benefits of integrating technology in patient care are evident, challenges such as ensuring data privacy, addressing disparities in technology access, and maintaining patient-clinician relationships in a digital world remain. Addressing these challenges is essential for the successful implementation of technology-driven patient engagement strategies.


The integration of technology in patient engagement signifies a critical shift in the approach to managing chronic metabolic diseases. The advancements in medical technology are not merely a trend but a fundamental change in the landscape of patient-centered healthcare. These innovations promise a future where the management of chronic diseases is more personalized, effective, and empowering for patients. Collaborative efforts among healthcare professionals, technologists, and patients are vital in realizing the full potential of these technological advancements, paving the way for a more efficient and effective healthcare system.


  1.  Dr Shashank Joshi  et al “Evaluation of Digital Twin (DT) in Improving HbA1c and Body Weight.” EASD 2023.
  2. Shamanna, P., Saboo, B., Damodharan, S. et al. Reducing HbA1c in Type 2 Diabetes Using Digital Twin Technology-Enabled Precision Nutrition: A Retrospective Analysis. Diabetes Ther 11, 2703–2714 (2020). DOI.

By Dr. Paramesh Shamanna, Medical Director, Twin Health

Consultant Diabetologist, Manipal Hospital, Columbia Asia Hospital, Bangalore Diabetes


Medical Director, Twin Health

Director, Bangalore Diabetes Centre, Diet Delite Pvt Ltd


Life Member, Research Society for the Study of Diabetes in India (RSSDI), Foot Society of



Clinical Trials:

Principal Investigator in over 120 clinical trials, including TECOS, SAVOR, LEADER, CANVAS,


Presentations and Publications:

Speaker at numerous national and international forums

Multiple national and international publications

Presented at various conferences including ECE, ADA, AACE, ESI, ICE, ACVC, IDF


Founder, Bangalore Diabetes Centre, 1999

The centre provides comprehensive diabetic care, with facilities for total care of diabetes

including specialists from fields such as ophthalmology, nephrology, foot care, and more.


Memberships and Awards:

Life Member, Research Society for the Study of Diabetes in India

Life Member, Foot Society of India

Best Citizen of the year, Lions Club, 2017



2022 Paul Dudley White International Award recipient, selected as a top scoring abstract

author by the American Heart Association International. This award is sponsored by

American Heart Association International and the Paul Dudley White Endowment.

Must Read
Related Articles